Concepedia

Anne E. Mayer Bridwell

AE

Statistics

Publications

5

Citations

378

H-Index

5

Active since

2019

Affiliations

Washington University in St. Louis(Current)

University of Cincinnati

Harvard University

University of California, San Francisco

German Primate Center

Anne E. Mayer Bridwell is an author at Washington University in St. Louis specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2019–2023

5

Publications

5

A promising bioconjugate vaccine against hypervirulent <i>Klebsiella pneumoniae</i>

Mario F. Feldman, Anne E. Mayer Bridwell, Nichollas E. Scott et al. · Proceedings of the National Academy of Sciences · 2019 · 196 citations · Full text

, , +15

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell et al. · Proceedings of the National Academy of Sciences · 2021 · 119 citations · Full text

, , +14

Identification of 4-Amino-Thieno[2,3- <i>d</i> ]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis

Gregory A. Harrison, Anne E. Mayer Bridwell, Megh Singh et al. · mSphere · 2019 · 36 citations · Full text

, , +17

Design, Synthesis, and Evaluation of Novel Δ<sup>2</sup>-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant <i>Mycobacterium tuberculosis</i> Mutant

Souvik Sarkar, Anne E. Mayer Bridwell, James A. D. Good et al. · Journal of Medicinal Chemistry · 2023 · 14 citations · Full text

, , +17

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 13 citations · Full text

, , +14

1–5 of 5